Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Consensus Recommendation of “Hold” by Analysts
Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have been given a consensus recommendation of “Hold” by the nine analysts that are presently covering the stock, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year […]
Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have been given a consensus recommendation of “Hold” by the nine analysts that are presently covering the stock, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year […]
